Medicines and Medical Devices Safety Independent Review

Department of Health and Social Care written question – answered on 1st September 2020.

Alert me about debates like this

Photo of Jon Trickett Jon Trickett Labour, Hemsworth

To ask the Secretary of State for Health and Social Care, what assessment he has made of the recommendations outlined in the Independent Medicines and Medical Devices Safety Review.

Photo of Jon Trickett Jon Trickett Labour, Hemsworth

To ask the Secretary of State for Health and Social Care, whether he will take steps to implement the recommendations in the Independent Medicines and Medical Devices Safety Review.

Photo of Jon Trickett Jon Trickett Labour, Hemsworth

To ask the Secretary of State for Health and Social Care, if he will implement the recommendations in Chapter 4 of the Independent Medicines and Medical Devices Safety Review on the use of Sodium Valproate in pregnancy.

Photo of Nadine Dorries Nadine Dorries Minister of State (Department of Health and Social Care)

The Independent Medicines and Medical Devices Safety Review published its report on the 8 July and all of its recommendations will be considered carefully. The Government will provide an update in due course.

The Medicines and Healthcare products Regulatory Agency (MHRA) is working with stakeholders to improve compliance with the valproate Pregnancy Prevention Programme which aims to rapidly reduce and eventually eliminate pregnancies exposed to valproate. The MHRA is also working on developing a valproate registry, the main aims of which would be to monitor the use of valproate in girls and women in the United Kingdom and compliance with the current regulatory position, and to identify and monitor any children born to women on valproate.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.